Vaccine News and Research

Latest Vaccine News and Research

Study on B lymphocytes may contribute to the optimization of vaccines

Our bodies can fine-tune the immune response to an infection and make it proportional to the threat at hand.

15 Sep 2021

SARS-CoV-2 variants show substantial differences in spike structure

To investigate the impact of these mutations, researchers performed cryo-electron microscopy analysis on the variants spike proteins to determine any structural changes.

15 Sep 2021

Natural SARS-CoV-2 infection induces more durable immunity than vaccination study suggests

Scientists from the USA have demonstrated that immunity induced by mRNA-based COVID-19 vaccines in previously SARS-CoV-2-infected people has the highest robustness and durability with cross-reactivity against different viral variants.

15 Sep 2021

Vaccination of children before school reopening may control COVID-19 pandemic

A team has recently explored the impact of non-pharmaceutical control measures and vaccination on the COVID-19 pandemic during school reopening in England.

15 Sep 2021

Over half of states have rolled back public health powers in pandemic

Republican legislators in more than half of U.S. states, spurred on by voters angry about lockdowns and mask mandates, are taking away the powers state and local officials use to protect the public against infectious diseases.

15 Sep 2021

Biden releases a new plan to combat covid, but experts say there’s still a ways to go

On the campaign trail last year, Joe Biden promised that, if elected president, he would get covid-19 under control. Since assuming office in January, Biden has continued to pledge that his administration would do its best to get Americans vaccinated against covid and allow life to return to some semblance of normal.

15 Sep 2021

A sweet pill to swallow: oral nucleoside analog of Remdesivir improved SARS-CoV-2 pathogenesis in mice

A new study focused on in vitro antiviral activity in various cell models and in vivo therapeutic efficacy of oral GS-621763 in a mouse model of SARS-CoV-2 pathogenesis.

15 Sep 2021

Deep profiling of SARS-CoV-2 immune response amongst the mildly symptomatic

In a research paper recently uploaded to the medRxiv* preprint server by Capelle et al. (September 2nd, 2021), the immune response of mild and hospitalized COVID-19 patients is compared, finding that early T-cell response is a vital indicator of SARS-CoV-2 disease severity.

15 Sep 2021

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for Covid-19, some of the same events which have led to restricted use of the Oxford-AstraZeneca vaccine in a number of countries.

15 Sep 2021

Study highlights need to accelerate COVID-19 vaccination in the U.S.

Researchers in the United States have warned that as of July 15th this year (2021), the level of population immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may still have been insufficient to contain infection outbreaks and safely return to pre-pandemic social behavior.

15 Sep 2021

Pregnancy complications with COVID-19

An important new article published in the Clinical Medicine Journal discusses pregnancy complicated with COVID-19.

14 Sep 2021

Flu shots and COVID-19 immunity

A new paper finds that the influenza vaccine may influence both the response to and incidence of infection by the SARS-CoV-2.

14 Sep 2021

Prior symptomatic COVID-19 enhances mRNA vaccine response

A new paper describes the antibody responses in people who have already been infected with SARS-CoV-2 and are vaccinated as compared to the naïve.

14 Sep 2021

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

14 Sep 2021